The outbreak of COVID-19 is expected to have a minimal or negligible negative impact on the cell therapy technologies market. The rise in the incidences of COVID has led to an increase in the need for an efficient drug or vaccine for COVID, which could help in reducing the severity of the cases. Cell-based research is an essential step during the manufacturing of vaccines, which can help in the growth of the market.
What the Market Looks Like?
The cell therapy technologies market is projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 14.4% from 2020 to 2025. North America commanded the largest share of the cell therapy technologies market in 2020.
The emerging economies such as Australia and China are expected to provide a wide range of growth opportunities for players in the market which is driven by their large and growing populations as well as increase in the number of clinical trials and investments in the field of personalized medicine in these countries.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978
What are Key Trends in the Market?
The growth of the Cell Therapy Technologies Market is primarily influenced by the following factors:
- Rising government investments in cell-based research
- Rising incidence of chronic and infectious diseases
- Large number of oncology-related cell therapy clinical trials
- Increasing GMP certifications for cell therapy production facilities
On the basis of product, the market is segmented into consumables, equipment, and systems & software. The consumables segment accounted for the largest share of the cell therapy technologies market in 2019. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.
Read more about Cell Therapy Equipment Market@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=213334978
